Pulsed electromagnetic field therapy

Pulsed electromagnetic field therapy has been studied in 10 papers since 2021: 5 trials in people, 4 in animals, 1 review; 6 in the past year.

Intervention

10 papers study it27 findingsUpdated

See all 9 papers on pulsed electromagnetic field therapy

At a glance

The findings reach people, from one lab or study. 7 independent labs in 5 countries.

“PEMF significantly increased extension peak torque compared to the SHAM group at 6-month post-intervention (p = 0.042).”
Pulsed Electromagnetic Field Therapy for Mild-to-Moderate Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical TrialJournal of cachexia, sarcopenia and muscle2026doi:10.1002/jcsm.70199

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 7 independent labs in 5 countries
  • Funders: Foundation for Research Support of Goias State and 6 more
  • Human trial5
  • Animals4

Studies in people

4 studies gave pulsed electromagnetic field therapy to people and measured what changed.

What changedDesignPeopleSource

up: Improves knee extension strength72% vs 25% increase at 6 months

no change: Has no effect on lean muscle mass

Randomized trial8 weeks60 peopleBoth50 and olderMidlife adults; Older adults; refractory mild-to-moderate knee osteoarthritisJournal of cachexia, sarcopenia and muscle, Jan 27, 2026

no change: Has no effect on atherosclerotic cardiovascular disease risk-0.16%, P=0.43

up: Improves lower extremity function+27.48%, P=0.001

Randomized trial8 weeks14 people45-60 yearsMidlife adults; type 2 diabetes mellitusAmerican journal of cardiovascular disease, Dec 15, 2025

up: Improves knee extensor strength

up: Improves functional performance

no change: Has no effect on calf circumference

Trialfour weeks25 peopleElderly adults with sarcopeniaLife (Basel, Switzerland), Jul 16, 2025

down: Decreases pain-3.2 ± 1.2, P = .028

down: Decreases stiffness-1.4 ± 0.6, P = .038

up: Improves physical function-9.0 ± 3.6, P = .039

Randomized trial4 months60 peopleolder adultsOlder adults; knee osteoarthritisJournal of geriatric physical therapy (2001), Jan 27, 2025

What did studies of pulsed electromagnetic field therapy find?

25

Studies of pulsed electromagnetic field therapy measured 25 outcomes, among them functional performance, knee extensor strength and bone marrow adiposity.

Functional performance

upin humans1

1 study
  1. Pulsed electromagnetic field therapy improves functional performance in humans (sarcopenia).

    “Additionally, the interaction between time and group was also significant (F1,14 = 7.521, p = 0.016; η2p = 0.349), indicating that the change in TUG performance differed between groups over the analyzed period.”

    Human trialsarcopeniafour weeks

    The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention

    Life (Basel, Switzerland)

  2. Pulsed electromagnetic field therapy improves functional performance in older adults with sarcopenia (from 23.1 ± 14.4 to 18.7 ± 10 s (p = 0.048)).

    “TUG test time improved from 23.1 ± 14.4 to 18.7 ± 10 s (p = 0.048)”

    Human trialin older adults with sarcopenia12 sessionsn = 25

    The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention

    Life (Basel, Switzerland)

Knee extensor strength

upin humans1

1 study
  1. Pulsed electromagnetic field therapy improves knee extensor strength in humans (sarcopenia).

    “Additionally, a significant interaction effect between time and group was identified (F1,14 = 12.318, p = 0.003; η2p = 0.468), suggesting that the degree of increase in lower-limb strength over time differed between groups.”

    Human trialsarcopeniaknee extensorfour weeks

    The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention

    Life (Basel, Switzerland)

  2. Pulsed electromagnetic field therapy improves knee extensor strength in older adults with sarcopenia (from 13.05 ± 4.8 kgf to 18.56 ± 8 kgf (p < 0.001)).

    “Significant improvements were observed in knee-extension strength, which increased from 13.05 ± 4.8 kgf to 18.56 ± 8 kgf (p < 0.001)”

    Human trialin older adults with sarcopeniaquadriceps and gastrocnemius muscles12 sessionsn = 25

    The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention

    Life (Basel, Switzerland)

Bone marrow adiposity

downin rats1

1 study
  1. Pulsed electromagnetic field therapy decreases bone marrow adiposity in ovariectomized rats.

    “enhanced bone formation rate, and reduced bone marrow adiposity”

    Animalsin ovariectomized rats8 weeks

    Pulsed electromagnetic field drives osteogenic and suppresses adipogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin signaling to ameliorate osteoporosis

    Bone reports

Trabecular bone mass

upin rats1

1 study
  1. Pulsed electromagnetic field therapy improves trabecular bone mass in ovariectomized rats.

    “daily PEMF exposure for 8 weeks significantly preserved trabecular bone mass and microarchitecture”

    Animalsin ovariectomized rats8 weeks

    Pulsed electromagnetic field drives osteogenic and suppresses adipogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin signaling to ameliorate osteoporosis

    Bone reports

Wnt/β-catenin signaling

upin rat cells1

1 study
  1. Pulsed electromagnetic field therapy activates wnt/β-catenin signaling in dexamethasone-treated rat BMSCs.

    “PEMF activates the canonical Wnt/β-catenin pathway”

    Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT

    Pulsed electromagnetic field drives osteogenic and suppresses adipogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin signaling to ameliorate osteoporosis

    Bone reports

More on Wnt/β-catenin signaling

Adipogenesis

downin rat cells1

1 study
  1. Pulsed electromagnetic field therapy decreases adipogenesis in dexamethasone-treated rat BMSCs.

    “concurrently suppressing adipogenesis in vitro”

    Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT

    Pulsed electromagnetic field drives osteogenic and suppresses adipogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin signaling to ameliorate osteoporosis

    Bone reports

Osteogenic differentiation

upin rat cells1

1 study
  1. Pulsed electromagnetic field therapy improves osteogenic differentiation in dexamethasone-treated rat BMSCs.

    “promoting osteogenic differentiation and concurrently suppressing adipogenesis in vitro”

    Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT

    Pulsed electromagnetic field drives osteogenic and suppresses adipogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin signaling to ameliorate osteoporosis

    Bone reports

Trabecular bone

upin rats1

1 study
  1. Pulsed electromagnetic field therapy increases trabecular bone in a rat model of osteosarcopenia.

    “We found that PEMF enhance the synthesis of osteogenic and myogenic proteins, leading to an increase in both the quantity and density of trabecular bone and myotubes.”

    Animalsin a rat model of osteosarcopeniabone15 Hz, 2.0 mT12 weeksfemales

    Pulsed electromagnetic field effectively improves musculoskeletal degeneration and inflammation levels in a rat model of osteosarcopenia: an experimental study

    Frontiers in immunology

IL-6

downin rats1

1 study
  1. Pulsed electromagnetic field therapy decreases IL-6 in a rat model of osteosarcopenia.

    “Moreover, PEMF treatment attenuated the systemic chronic inflammatory milieu, as evidenced by reduced circulating levels of IL-6 and TNF-α”

    Animalsin a rat model of osteosarcopenia15 Hz, 2.0 mT12 weeksfemales

    Pulsed electromagnetic field effectively improves musculoskeletal degeneration and inflammation levels in a rat model of osteosarcopenia: an experimental study

    Frontiers in immunology

More on IL-6

Muscle atrophy

downin rats1

1 study
  1. Pulsed electromagnetic field therapy decreases muscle atrophy in a rat model of osteosarcopenia.

    “This intervention reduces the progression of bone loss and muscle atrophy while simultaneously improving the biological performance of muscle and bone.”

    Animalsin a rat model of osteosarcopeniaskeletal muscle15 Hz, 2.0 mT12 weeksfemales

    Pulsed electromagnetic field effectively improves musculoskeletal degeneration and inflammation levels in a rat model of osteosarcopenia: an experimental study

    Frontiers in immunology

More on Muscle atrophy

Lean muscle mass

no changein humans1

1 study
  1. Pulsed electromagnetic field therapy showed no clear effect on lean muscle mass in humans (refractory mild-to-moderate knee osteoarthritis).

    “Additionally, there were no differences between the PEMF and SHAM groups in lean muscle mass, cartilage thickness, mJSW, the 6-m walk time and the number of repetitions of chair standing in 30 s and WOMAC (all p > 0.05).”

    Human trialrefractory mild-to-moderate knee osteoarthritis8 weeksn = 60

    Pulsed Electromagnetic Field Therapy for Mild-to-Moderate Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

    Journal of cachexia, sarcopenia and muscle

Knee extension strength

upin humans1

1 study
  1. Pulsed electromagnetic field therapy improves knee extension strength in humans (refractory mild-to-moderate knee osteoarthritis) (72% vs 25% increase at 6 months).

    “PEMF significantly increased extension peak torque compared to the SHAM group at 6-month post-intervention (p = 0.042).”

    Human trialrefractory mild-to-moderate knee osteoarthritis8 weeksn = 60

    Pulsed Electromagnetic Field Therapy for Mild-to-Moderate Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

    Journal of cachexia, sarcopenia and muscle

Lower extremity function

upin humans1

1 study
  1. Pulsed electromagnetic field therapy improves lower extremity function in humans (type 2 diabetes mellitus) (+27.48%, P=0.001).

    “lower extremity function significantly increased by 64.62% (P<0.001), 27.48% (P=0.001), and 48.49% (P<0.001) in groups A, B, and C, respectively”

    Human trialtype 2 diabetes mellitus8 weeksn = 14

    Efficacy of exercise and electromagnetic field therapy on cardiovascular disease risk in patients with type 2 diabetes mellitus. Randomized controlled trial

    American journal of cardiovascular disease

Atherosclerotic cardiovascular disease risk

no changein humans1

1 study
  1. Pulsed electromagnetic field therapy showed no clear effect on atherosclerotic cardiovascular disease risk in humans (type 2 diabetes mellitus) (-0.16%, P=0.43).

    “non-significantly decreased by -0.16% (P=0.43) in group B”

    Human trialtype 2 diabetes mellitus8 weeksn = 14

    Efficacy of exercise and electromagnetic field therapy on cardiovascular disease risk in patients with type 2 diabetes mellitus. Randomized controlled trial

    American journal of cardiovascular disease

Depressive symptoms

downin humans1

1 study
  1. Pulsed electromagnetic field therapy decreases depressive symptoms in humans (sarcopenia) (7.9 ± 2.4 to 5.4 ± 1.7).

    “PEMF treatment led to a significant reduction in the individual scores (7.9 ± 2.4 to 5.4 ± 1.7), indicating an improvement in the depressive state (p = 0.0013). shows the effects of PEMF treatment pre- and post-intervention.”

    Human trialsarcopeniafour weeksn = 25

    The Effects of Pulsed Electromagnetic Field (PEMF) on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia: A Short-Term Intervention

    Life (Basel, Switzerland)

All 25

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 05 papers in 12 months